S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Harvard Bioscience Inc

HBIO XNAS
$6.89 +0.10 (+1.55%) ▲ 15-min delayed
Open
$6.90
High
$7.13
Low
$6.79
Volume
14.3K
Market Cap
$31.10M

About Harvard Bioscience Inc

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 339 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $86.55M $-56,700,000 $-1.28
FY 2025 $86.55M $-56,700,000 $-1.28
Q3 2025 $20.59M $-1,231,000 $-0.03
Q2 2025 $20.45M $-2,282,000 $-0.05

Related Market News

No specific coverage for HBIO yet. Check out our latest market news or earnings calendar.

Get HBIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Harvard Bioscience Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.